Generic Drugs

STAT Plus: Senate bill to encourage generic drug development would yield $3.3 billion in savings

A Senate bill that would give generic companies a pathway for suing brand-name rivals when denied access to needed samples would lower federal …

U.S. Congress

Lawmakers consider easing costs on drug companies as part of opioids deal

Lawmakers are considering adding a provision easing costs on drug companies to an opioid package currently being negotiated.<p>The powerful …

Opioids

Patent Granted on Gilead Hep C Drug Sparks Outrage in Brazil

Brazilian pharmaceutical companies and public interest groups are gearing up to challenge a hepatitis-drug patent granted to Gilead Sciences Inc., …

Law

Truvada Cost Could Be Lowered By UK Court Ruling - them.

Truvada — the HIV antiretroviral routinely prescribed as PrEP, which has been linked to a dramatic drop in new cases of HIV infection — is expensive. …

LGBTQI

Generics would hit the market faster under Senate bill, saving more than $3B, says CBO

Lower-price drugs would hit the market faster under a bipartisan bill awaiting a vote in the Senate, according to a score released Wednesday by the …

U.S. Politics

The Secret Drug Pricing System Middlemen Use to Rake in Millions

Not everybody reads the legal notices inside the Ottumwa Courier. But in January, Iowa pharmacist Mark Frahm noticed something unusual in the …

CVS Health

NYT Is Badly Mistaken: China Has Many Many Options in Trade War with Trump | Beat the Press

View Comments<p>The NYT erred badly with an article that told readers, "China Once Looked Tough on Trade: Now Its Options Are Dwindling." The article …

General Motors

Congress Wants to Ensure That All Pharmacists Can Help Patients Save Money on Prescriptions

The Senate passed a bill yesterday that would outlaw gag clauses in pharmacists' contracts. But will it really make a difference in medication …

Insurance

Does Ajovy's Approval Make Teva a Pain-Free Stock to Buy?

Let's see if a new migraine prevention drug can help return to growth.<p>Borrowing heavily to become the world's leading generic drug company just as …

Teva

Aceto Corp. expects an annual loss of at least $240M; delays annual report

Port Washington-based drug company Aceto said in a government filing that it expects to report a loss of at least $240 million in its fiscal year …

Long Island

NJ Politics Digest: Murphy Reaches Money-Saving Health Deal With Unions

The Murphy administration says a health care deal it has reached with the state’s public workers’ unions will save about $500 million over two …

New Jersey

Fed up with Drug Shortages, This Hospital Decided to Make Its Own Generics

Instead of demanding more government intervention, they looked to actually solve the problems of poor supply and unpredictable prices.<p>Governments are …

Health Care

Fosun Pharma Sees 'Huge' Opportunities in India, Southeast Asia, Africa

Fosun Pharma Chairman Chen Qiyu.<p>Fosun International, led by Shanghai billionaire Guo Guangchang, has long made a name for itself through international partnerships and investments. Fosun Pharma, Fosun’s pharmaceutical arm, is also stepping up its international ties, recently setting up subsidiaries …

South-east Asia

New to Medicare? Make sure you understand prescription drug coverage

Deductibles. Copayments. Coverage Gaps.<p>For those new to Medicare, how prescription drugs are covered is important. Yet the language we use can be …

Deductible

Teva stock surges 7% after FDA approves migraine medication

Teva Pharmaceutical Industries Ltd. TEVA, +4.20% shares surged nearly 7% in Monday premarket trade after the company's migraine therapy, intended to …

Teva

Why Gilead Stock Is a Sleepy Giant Waiting to Break Out

<b>Gilead Sciences</b> (NASDAQ:<b>GILD</b>) stock is stuck in a range and for good reason. The markets cannot decide if its quarterly revenue declines are …

Genetics

How To Get Cheaper Prescription Drugs

Just Now<p>A new national poll by a non profit, non partisan health care research organization finds three quarters of Americans consider the cost of …

University of Chicago

Drug Rebates Aren’t ‘Kickbacks’

A rule designed to save patients money would end up having the opposite effect.<p>The Trump administration is close to issuing a new rule that could effectively ban rebate payments from drug manufacturers to pharmaceutical benefit managers, or PBMs. The plan is misguided. A full ban would backfire and …

Trump Administration

India in a catch-22 situation on free trade pact with the US

Amiti SenThe government seems to be in two minds about whether it should go in for a free trade agreement (FTA) with the US. While many officials are

Trade Pact

Sift Through Your Medicare Choices

Even if you are happy with your current plan, check out your options. You may find a better deal.<p><i>EDITOR'S NOTE: This article was originally published</i> …

Health Care

Contribute to make healthcare affordable, young researchers told

In spite of independent India making giant strides in various spheres, a number of challenges, including provision of universal healthcare and making …

Generic Drugs

UN wins support to end TB after US dispute

Nations around the world have said they're ready to commit billions to eradicate tuberculosis. But the deal only came about after countries denied …

Public Health

[$$] The Worst Is Over for Generic-Drug Stocks

Look carefully, and there are signs that the generic drug industry’s long stock-market nightmare is ending. Prices declined faster than usual because …

FDA

Osmotica Pharmaceuticals on deck for IPO

Bridgewater, NJ-based Osmotica Pharmaceuticals plc (OSMT) has filed a preliminary prospectus for an IPO.<p>The biopharmaceutical firm develops and …

Business

A pain reliever

Focus on the high-margin products and launches lined up in the US are key drivers

Business (India)

Drug exec blasted for claiming 'moral' right to hike antibiotic prices, supporting 'pharma bro' Shkreli

Move over, “Pharma Bro.” A new CEO is in the running as the pharmaceutical industry’s most despised executive after claiming he has the “moral” right to raise the price of a crucial antibiotic.<p>Nirmal Mulye, chief executive of drug company Nostrum Laboratories, is facing fierce backlash after …

Martin Shkreli

Pressure intensifies on top drug lobbyist to fix 'doughnut hole' issue

The pharmaceutical industry was dealt a significant blow on Thursday when a key provision impacting its payment obligations under the Medicare …

U.S. Politics

Daily Headlines: September 14

<b>POLITICS</b> <br>Trump faces big test on Hurricane Florence <br>By Robert Donachie<p><b>HEALTHCARE</b><br>Free market reforms can fix the problem of generic drug price spikes …

U.S. Politics

Free market reforms can fix the problem of generic drug price spikes

Prescription drug price spikes have been plaguing American patients, physicians, and hospitals. And they have drawn renewed scrutiny following the …

U.S. Politics

UPDATE 1-South Africa's Aspen to sell infant formula unit to...

(Adds detail)<p>JOHANNESBURG, Sept 13 (Reuters) - Aspen Pharmacare is selling its global infant formula business to French dairy group Lactalis for 12.9 billion rand ($864.5 million), the African drugmaker said in a results statement on Thursday.<p>The so-called nutritionals business sells infant milk …

Intellectual Property